Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323

Clinical trial NCT00484536 · TERMINATED

Trial details

NCT number: NCT00484536
Sponsor: UCB Pharma
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2007-05-01
Primary completion: 2009-11-01
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.